EMT typically initiates metastasis during cancer progression, during which epithelial cells acquire migration and invasion characteristics, and MMPs’ expression increases, with the loss of E-cadherin and gain of N-cadherin and Vimentin [54,55,56]. The gene discussed is CDH2; the disease is cancer.